Evicenter
P&T meetings

SL1009 (sodium dichloroacetate)

Pyruvate dehydrogenase complex deficiency

Manufacturer
Saol Therapeutics
Regulatory submission
NDA resubmitted June 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionProduct descriptionProduct information

Special populations

1 evidence topic · 1 source

Age-related pharmacokinetics

“a striking age-dependent decrease in its plasma clearance and an increase in its plasma half-life in patients and rats.” (opens the source at this quote in a new tab)

Pregnancy, lactation, and reproductive potential

No evidence found.

Renal impairment: SL1009-specific dosing

No evidence found.

Hepatic impairment: SL1009-specific dosing

No evidence found.